Basics |
Gyre Therapeutics, Inc.
|
IPO Date: |
August 21, 2015 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$649.1M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.29 | 3.85%
|
Avg Daily Range (30 D): |
$0.23 | 2.91%
|
Avg Daily Range (90 D): |
$0.43 | 4.84%
|
Institutional Daily Volume |
Avg Daily Volume: |
.43M |
Avg Daily Volume (30 D): |
.12M |
Avg Daily Volume (90 D): |
.18M |
Trade Size |
Avg Trade Size (Sh.): |
244 |
Avg Trade Size (Sh.) (30 D): |
65 |
Avg Trade Size (Sh.) (90 D): |
71 |
Institutional Trades |
Total Inst.Trades: |
120 |
Avg Inst. Trade: |
$1.59M |
Avg Inst. Trade (30 D): |
$1.63M |
Avg Inst. Trade (90 D): |
$1.45M |
Avg Inst. Trade Volume: |
.46M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.83M |
Avg Closing Trade (30 D): |
$3.74M |
Avg Closing Trade (90 D): |
$1.85M |
Avg Closing Volume: |
584.83K |
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$.03
|
$
|
$.14
|
Diluted EPS
|
$
|
$
|
$.05
|
Revenue
|
$ 22.06M
|
$ 27.87M
|
$ 105.76M
|
Gross Profit
|
$ 21.16M
|
$ 26.7M
|
$ 101.87M
|
Net Income / Loss
|
$ 3.73M
|
$ .57M
|
$ 17.9M
|
Operating Income / Loss
|
$ 2.27M
|
$ .6M
|
$ 16.16M
|
Cost of Revenue
|
$ .89M
|
$ 1.18M
|
$ 3.88M
|
Net Cash Flow
|
$ 3.18M
|
$ -3.8M
|
$ -21.42M
|
PE Ratio
|
|
|
|
Splits |
Jan 13, 2023:
2:1
|
Feb 13, 2017:
1:15
|
Aug 21, 2015:
1:7
|
|
|
|